A Study of Sasanlimab in People With Non-muscle Invasive Bladder Cancer

To join this study, your doctor would first need to check if you meet certain requirements. Generally, you would need to have a specific type of early-stage bladder cancer that hasn't spread into the bladder muscle and has been confirmed by a doctor. All visible cancer would need to have been recently removed by surgery.

If your cancer had not responded well to previous BCG treatment, you might have been considered for one part of the study (though this part is no longer taking new participants). A key point is that you should either have refused or be unable to have an operation to remove your bladder (called a radical cystectomy).

There are also reasons why you wouldn't be able to join. For example, if your bladder cancer has spread into the muscle or to other parts of your body, or if you've already had certain types of immunotherapy or radiation treatment to your bladder, you wouldn't be eligible. Also, if you received BCG treatment within the last two years (for Part A of the study), you wouldn't qualify. Your doctor will be able to discuss all these details with you.

Taking part in a study like this typically involves regular visits to the study clinic. During these visits, you would receive the study medicine, sasanlimab, which is given as an injection under the skin (subcutaneous), and potentially BCG, which is given into the bladder (intravesical). Doctors and nurses would carefully monitor your health and check for any side effects. You would also have physical examinations, blood tests, and scans or procedures like cystoscopies to check your bladder and see how the cancer is responding.

The exact number and frequency of visits, as well as the total length of your participation, would depend on which treatment group you are in and how your body responds. There would be an initial treatment period, often followed by a period where treatment might be given less frequently, and then a follow-up period to continue monitoring your health and the cancer. All these details would be fully explained to you before you decide to join.